Lenalidomide Dose Modifications and Associated Patient Outcomes in Newly Diagnosed Multiple Myeloma (NDMM)

Autor:	X.H. Hu, Steven R. Arikian, J. Lee, Frank A. Corvino, Mohamad A. Hussein, Gary Binder, Andy Surinach, Yasir Nagarwala, Saad Z. Usmani
Rok vydání:	2015
Předmět:	Oncology Cancer Research medicine.medical_specialty business.industry Hematology Newly diagnosed medicine.disease Internal medicine Medicine business Multiple myeloma Lenalidomide medicine.drug
Zdroj:	Clinical Lymphoma Myeloma and Leukemia. 15:e257-e258
ISSN:	2152-2650
DOI:	10.1016/j.clml.2015.07.546
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a545609ec4d7b463434c0061d4d53ad8 https://doi.org/10.1016/j.clml.2015.07.546 Zobrazit plný text záznamu Full Text from ScienceDirect